Should Low-Grade Prostate Cancer Be Considered Cancer?

Healthcare Unfiltered

English - January 17, 2023 11:48 - 56 minutes - 104 MB - ★★★★★ - 125 ratings
Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The History and Future of Precision Medicine with Ray Kurzrock

Next Episode: Diet, Exercise, and Lifestyle Decisions for Cancer Patients With Urvi Shah and Neil Lyengar

Scott Eggener, MD, University of Chicago, and Jonathan Epstein, MD, The Johns Hopkins Medical Institutions, join the show to debate whether Gleason Score 6 prostate cancer should be renamed to non-cancer. The trio hit on what should happen upon diagnosis and Gleason grade 6, which patients should be offered active surveillance, the benefits and risks of not calling this diagnosis “cancer,” how often and how frequently to biopsy, overscreening, and many other discussion points.

Read Dr. Eggener’s editorial in the Journal of Clinical Oncology.
https://ascopubs.org/doi/full/10.1200/JCO.22.00123

Read Dr Epstein’s response in the Journal of Clinical Oncology.
https://ascopubs.org/doi/full/10.1200/JCO.22.00926

Check out Chadi’s website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/

Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA